Mongersen

GED-0301 · Celgene

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Mongersen, covering 2017-11-14 to 2019-01-29. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease [Phase 3]